(1)
Lorenzo, R. B.; Lorenzo, L. S.; González-Martín, A. Will the Carboplatin-Paclitaxel-Bevacizumab Combination Become the Preferred Option As the First Line in Advanced Cervical Cancer? A Small Experience from a Single Oncologic Center:  . CBN 2017, 5, 21-24.